I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The Future of Epidemic and Pandemic Vaccines to Serve Globa..:
Farlow, Andrew
;
Torreele, Els
;
Gray, Glenda
...
https://discovery.ucl.ac.uk/id/eprint/10167728/1/Epidemic%20vaccines%20for%20public%20health_Vaccine_March2023.pdf. , 2023
Link:
https://discovery.ucl.ac.uk/id/eprint/10167728/1/Epide..
RT Journal T1
The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs
UL https://suche.suub.uni-bremen.de/peid=base-ftucl:oai:eprints.ucl.ac.uk.OAI2:10167728&Exemplar=1&LAN=DE A1 Farlow, Andrew A1 Torreele, Els A1 Gray, Glenda A1 Ruxrungtham, Kiat A1 Rees, Helen A1 Prasad, Sai A1 Gomez, Carolina A1 Sall, Amadou A1 Magalhães, Jorge A1 Olliaro, Piero A1 Terblanche, Petro PB MDPI AG YR 2023 K1 COVAX K1 COVID-19 vaccine lessons K1 R&D blueprints K1 controlling transmission K1 disease X and pathogen X K1 epidemic and pandemic prevention K1 low- and middle-income country (LMIC) vaccine innovation and manufacture K1 mRNA) K1 modular vaccine production K1 mucosal immunity K1 pan-coronavirus vaccines K1 platform technologies (esp. inactivated viruses K1 public investments and subsidies K1 recombinant proteins K1 regulatory challenges K1 technology global commons and global public goods K1 vaccine access K1 vaccine business model and value proposition K1 vaccine intellectual property (IP) and know-how transfer K1 vaccine prototypes K1 variants and booster strategies K1 viral vectors JF https://discovery.ucl.ac.uk/id/eprint/10167728/1/Epidemic%20vaccines%20for%20public%20health_Vaccine_March2023.pdf LK http://dx.doi.org/https://discovery.ucl.ac.uk/id/eprint/10167728/1/Epidemic%20vaccines%20for%20public%20health_Vaccine_March2023.pdf DO https://discovery.ucl.ac.uk/id/eprint/10167728/1/Epidemic%20vaccines%20for%20public%20health_Vaccine_March2023.pdf SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)